Journal of Immunology Research / 2014 / Article / Tab 4

Research Article

Serum Level of Antibody against Benzo[a]pyrene-7,8-diol-9,10-epoxide-DNA Adducts in People Dermally Exposed to PAHs

Table 4

The effectiveness of the therapy (PASI score).

CCT contentPASI scoreStatistical significance of differences  Efficiency (%)
Before GTAfter GT

CCT-3% ( )16.20 (12.70–20.85)7.80 (6.60–10.70) 50.9   (41.9–60.58)
CCT-5% ( )17.10 (14.80–20.60)6.05 (4.30–7.95) 62.7 (52.4–74.0)
Statistical significance of differences NS

The effectiveness of the therapy is expressed as the PASI score; the values are presented as median (lower–upper quartile) because of nonnormal data distribution; : number of subjects; : Wilcoxon matched-pairs test.
Calculation of the efficiency of the treatment: (100 − [PASI after GT/PASI before GT] 100).

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.